Literature DB >> 3280411

European Organization for Research on Treatment of Cancer trials using radiotherapy with multiple fractions per day. A 1978-1987 survey.

J C Horiot1, W van den Bogaert, K K Ang, E Van der Schueren, H Bartelink, D Gonzalez, M de Pauw, M van Glabbeke.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3280411     DOI： 10.1159/000415105

Source DB:  PubMed          Journal:  Front Radiat Ther Oncol        ISSN： 0071-9676


× No keyword cloud information.
  8 in total

1.  Multiple-fraction-per-day external beam radiotherapy for adults with supratentorial malignant gliomas.

Authors:  E C Halperin
Journal:  J Neurooncol       Date:  1992-11       Impact factor: 4.130

2.  Hyperfractionated radiotherapy for T2 glottic cancer for preservation of the larynx.

Authors:  Ichiro Tateya; Shigeru Hirano; Hisayoshi Kojima; Koichi Omori; Kazuhiko Shoji; Michihide Mitsumori; Yasushi Nagata; Juichi Ito
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-07-13       Impact factor: 2.503

3.  Radiation therapy of pathologically confirmed newly diagnosed glioblastoma in adults.

Authors:  John Buatti; Timothy C Ryken; Mark C Smith; Penny Sneed; John H Suh; Minesh Mehta; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2008-08-20       Impact factor: 4.130

4.  Short-course radiotherapy in elderly patients with glioblastoma: feasibility and efficacy of results from a single centre.

Authors:  L Fariselli; V Pinzi; I Milanesi; A Silvani; M Marchetti; M Farinotti; A Salmaggi
Journal:  Strahlenther Onkol       Date:  2013-04-28       Impact factor: 3.621

5.  Prolonged survival for patients with newly diagnosed, inoperable glioblastoma with 3-times daily ultrafractionated radiation therapy.

Authors:  Patrick Beauchesne; Valerie Bernier; Charlotte Carnin; Luc Taillandier; Mohamed Djabri; Laurent Martin; Xavier Michel; Jean-Philippe Maire; Toufic Khalil; Christine Kerr; Thierry Gorlia; Roger Stupp; Remy Pedeux
Journal:  Neuro Oncol       Date:  2010-02-11       Impact factor: 12.300

Review 6.  Improving Cancer Treatment via Mathematical Modeling: Surmounting the Challenges Is Worth the Effort.

Authors:  Franziska Michor; Kathryn Beal
Journal:  Cell       Date:  2015-11-19       Impact factor: 41.582

7.  Treating Glioblastoma Multiforme (GBM) with super hyperfractionated radiation therapy: Implication of temporal dose fractionation optimization including cancer stem cell dynamics.

Authors:  Victoria Y Yu; Dan Nguyen; Daniel O'Connor; Dan Ruan; Tania Kaprealian; Robert Chin; Ke Sheng
Journal:  PLoS One       Date:  2021-02-01       Impact factor: 3.240

8.  Canadian recommendations for the treatment of glioblastoma multiforme.

Authors:  W P Mason; R Del Maestro; D Eisenstat; P Forsyth; D Fulton; N Laperrière; D Macdonald; J Perry; B Thiessen
Journal:  Curr Oncol       Date:  2007-06       Impact factor: 3.677
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.